FDA Adverse Event Death Summary report: N

PREMICATH 1FR PICC

MDR report key: 4048348 · Received April 7, 2014

Report

Report Number
2245270-2014-00030
Event Type
Death
Date Received
April 7, 2014
Date of Event
September 28, 2012
Report Date
April 3, 2014
Manufacturer
VYGON CORP.
Product Code
LJS
PMA / PMN Number
K954302
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

ALTHOUGH THIS MALFUNCTION OCCURRED IN 2012, IT IS BEING REPORTED TO FDA AS A RESULT OF A 483 AUDIT OBSERVATION REGARDING MDR REPORTING GIVEN TO VYGON (B)(4) ON (B)(4) 2014. THIS COMPLAINT IS NOT CONFIRMED. FROM THE DESCRIPTION OF THE INCIDENT, IT SEEMS AS IF THE CATHETER WAS INSERTED WITHOUT CATHETER TIP POSITION CONTROL. UNFORTUNATELY, THE USER DID NOT IDENTIFY THE PREMATURE BABY'S SYMPTOMS, SO THAT THE PATIENT FINALLY DIED. THE USER OBVIOUSLY IGNORED THE WARNINGS IN THE CATHETER'S IFU REGARDING CARDIAC TAMPONADE AND THE NECESSITY TO AVOID CATHETER TIP PLACEMENT IN THE RIGHT ATRIUM. HAVING CHECKED BATCH HISTORY RECORDS, NO ABNORMALITIES WERE FOUND. DESPITE OF ONE SIMILAR INCIDENT IN (B)(6) 2009 IN THE USA, WHERE THE CATHETER'S TIP WAS PLACED INTO THE RIGHT ATRIUM, NO SIMILAR INCIDENTS OF CARDIAC TAMPONADE WERE REGISTERED WITHIN THE LAST 5 YEARS.

Description of Event or Problem · 1

BABY BECAME VERY UNWELL APPROXIMATELY SEVEN DAYS POST PLACEMENT OF PREMICATH FOR TPN. UNIT WERE UNABLE TO RESUSCITATE AND BABY DIED. PREMICATH WAS NOT RETAINED FOR INVESTIGATION. DURING THE POST MORTEM, TPN WAS DISCOVERED WITHIN THE PLEURAL CAVITY. NO X-RAYS OF TIP PLACEMENT AVAILABLE, AS NO CONTROL WAS DONE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
210258 PREMICATH 1FR PICC PUR INTRAVASCULAR CATHETER LJS VYGON CORP. 1261.21 061211GE

Patients

Seq Age Sex Outcome Treatment
1 Death